Fig. 5From: A novel pH- and glutathione-responsive drug delivery system based on in situ growth of MOF199 on mesoporous organic silica nanoparticles targeting the hepatocellular carcinoma nicheBlood pharmacokinetics of DOX (A) and SOR (B) were monitored in tumor-free BALB/c nude mice after intravenously injected with free DOX/SOR, D/S@MM, and D/S@SPMMBack to article page